ACS Medicinal Chemistry Letters (ACS Publications)
pubsdc3.acs.org › toc › amclctJul 10, 2014 · - Journal of Combinatorial Chemistry; ACS Earth and Space Chemistry; ACS Energy Letters; ACS Infectious Diseases; ACS Macro Letters; ACS Materials Letters - New in 2019; ACS Medicinal Chemistry Letters; ACS Nano; ACS Omega; ACS Pharmacology & Translational Science; ACS Photonics; ACS Sensors; ACS Sustainable Chemistry & Engineering; ACS ...
ACS Medicinal Chemistry Letters Archives - ACS Axial
axial.acs.org › topics › journalACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are ...
ACS Medicinal Chemistry Letters | Vol 12, No 3
https://pubs.acs.org/toc/amclct/12/311.03.2021 · ACS Medicinal Chemistry Letters 2021, 12, 3, 494-501 (Letter) Publication Date (Web): March 2, 2021. Abstract. Full text. PDF. ABSTRACT. Indoleamine 2,3-dioxygenase 1 (IDO1) has been identified as a target for small-molecule immunotherapy for the treatment of a variety of cancers including renal cell carcinoma and metastatic melanoma.